As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

Jonathan Bernstein, MD
Speaker: Shire, CSL Behring, Novartis/Genentech, Greer
Honorarium: Shire, CSL Behring, Novartis/Genentech, AstraZeneca, Greer
Consultant: Shire, Dyax, CSL Behring, Novartis/Genentech, AstraZeneca, Meda, Biocryst, Greer, Boehringer Ingelheim

Ben Bleier, MD
Consultant: Olympus, Arthrocare, Karl Storz
Stocks: Interscope

Larry Borish, MD
Consultant: Teva, Allakos, Knopp, Genentech/Novartis Data Safety Monitoring Board: Pluristem

Don Bukstein, MD
Speaker: AstraZeneca, Genentech, Meda, Merck, Novartis, Teva Circassia
Honorarium: AstraZeneca, Genentech, Meda, Merck, Novartis, Teva Circassia

Thomas Casale, MD
Consultant: AstraZeneca, Genentech, Novartis, Teva, Sanofi Regeneron, Boehringer Ingleheim, Circassia
Research: AstraZeneca, Genentech, Novartis, Teva, Sanofi Regeneron, Cytos

Rakesh Chandra, MD
Consultant: Johnson & Johnson, Olympus, Meda, Intersect
Research: Johnson & Johnson, Intersect
Honorarium: Johnson & Johnson, Olympus, Meda

Alexander G. Chiu, MD
Consultant: Olympus, Meda

Ray S. Davis, MD
Consultant: Teva, Merck, Meda, Mylan, AstraZeneca, Mylan & AANMA, Baxalta, Neohealth, Onyx & Noven & GNE
Speaker: Teva, Merck, Meda, Mylan, AstraZeneca, Mylan & AANMA
Honorarium: Teva, Merck, Meda, Mylan, AstraZeneca, Mylan & AANMA

David Hagaman, MD
Consultant: BreatheAmerica Speaker: Merck

Anju Peters, MD
Consultant: Baxter, Greer

Vijay Ramakrishnan, MD
Consultant: Acclarent, Medtronic Research: NeilMed

Raymond Sacks, MD
Consultant: Medtronic Speaker: Meda

Rodney Schlosser, MD
Consultant: Olympus, Meda Speaker: Entellus, IntersectENT

Russell Settipane, MD
Consultant: AstraZeneca, Teva, Merck
Speaker: Genentech, Mylan, Meda, Teva, Merck
Research Grant: Novartis, Genentech, Mylan, Oriel Therapeutics, Teva, Merck, Circassia
Employee/Stockholder: OceanSide Publications

Zachary M. Soler, MD
Consultant: Olympus

The Following have no financial relationships to disclose:
Tara Carr, MD Alan Gaines, MD Robert Kern, MD Ginny Loiselle Raj Sindwani, MD

Education Staff/Committee have no financial relationships to disclose, except as may be listed above.